Prosecution Insights
Last updated: July 17, 2026
Application No. 18/348,196

PHOTOSENSITIVE POLYIMIDE RESIN FOR ULTRAVIOLET (UV) CURING-BASED 3D PRINTING AND PREPARATION METHOD THEREOF

Non-Final OA §103
Filed
Jul 06, 2023
Priority
Mar 07, 2023 — CN 202310214490.4 +1 more
Examiner
WHITELEY, JESSICA
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Shaanxi University Of Technology
OA Round
1 (Non-Final)
89%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 89% — above average
89%
Career Allowance Rate
1342 granted / 1515 resolved
+23.6% vs TC avg
Moderate +7% lift
Without
With
+7.2%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 11m
Avg Prosecution
38 currently pending
Career history
1551
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
55.2%
+15.2% vs TC avg
§102
35.0%
-5.0% vs TC avg
§112
4.6%
-35.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1515 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 5-10 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on April 19, 2026. Priority Acknowledgment is made of applicant's claim for foreign priority based on an application filed in China on 3/7/2023. It is noted, however, that applicant has not filed a certified copy of the CN202310214490 application as required by 37 CFR 1.55. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 1 is rejected under 35 U.S.C. 103 as being unpatentable over Wang et al (CN 105837760) in view of Malik et al (US 10,036,952). With regards to claim 1, Wang teaches a polyimide photosensitive material for 3D printing (title) that contains a polyimide oligomer at a concentration from 50-60%, a reactive diluent at a concentration of 10-30%, and a free radical photoinitiator at a concentration of 2-5% (page 2). Wang teaches the reactive diluent to include the monomer a combination of N-vinylpyrrolidone and lauryl acrylate (page 4) reading on the claimed organic activator. Wang does not teach the claimed organic activator to include the monomer methyl methacrylate. Malik teaches a photosensitive polyimide compositions (title) that contains a polyimide polymer (abstract), a photoinitiator (abstract) and a solubility switching compound (abstract) that includes methyl (meth)acrylate (column 20, lines 19-43). Malik teaches the motivation for using this compound to be because it helps generate a contrast in the dissolution rate of the film prepared from the photosensitive composition before and after exposure (column 19, lines 55-67). Wang and Malik are analogous in the art of photosensitive polyimide compositions. In light of the discussion above, it would be obvious to one skilled in the art prior to the effective filing date of the present invention to add the MMA of Malik to the composition of Wang, thereby obtaining the present invention. Claims 2-4 is/are rejected under 35 U.S.C. 103 as being unpatentable over Wang et al (CN 105837760) in view of Malik et al (US 10,036,952) as applied to claim 1 above, and further in view of Liu et al (CN 113818098). The disclosure of Wang in view of Malik is adequately set forth in paragraph 5 above and is herein incorporated by reference. With regards to claims 2-4, Wang teaches the polyimide to be formed from a reaction from an imididimide compound and an anhydride compound with triethylamine, hydroquinone (reading on an inhibitor), a solvent that includes N-methylpyrrolidone, and glycidyl methacrylate (page 2). Wang teaches the amount of imide compound to be 0.05 moles, the amount of 0.1 moles of the maleic anhydride, catalytic amounts of triethylamine, catalytic amounts of hydroquinone, and 0.15-0.2 moles of glycidyl methacrylate (page 2). Wang does not teach the reactants to include 2-(4-aminophenyl)-5-aminobenzimidazole and 3,3’,4,4’-benzonphenone tetracarboxylic dianhydride (BTDA). Liu teaches the preparation of a polyimide (title) for 3D printing (page 2) that is a reaction of 2-(4-aminophenyl)-5-aminobenzimidazole (BIA) dianhydride with 3,3’,4,4’-dibenzone tetraic anhydride (BTDA). Liu teaches the motivation for using these reactants to be because the polyimide formed is a low complex process, low cost, and high efficiency (page 2). Wang, Malik, and Liu are analogous in the art of photosensitive polyimide compositions. In light of the benefit above, it would be obvious to one skilled in the art prior to the effective filing date of the present invention to use the reactants of Liu in Wang, thereby obtaining the present inventions Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSICA WHITELEY whose telephone number is (571)272-5203. The examiner can normally be reached 8 - 5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at 5712721130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JESSICA WHITELEY/Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Jul 06, 2023
Application Filed
May 18, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12674079
ADHESIVE MATERIAL AND DISPLAY APPARATUS
3y 6m to grant Granted Jul 07, 2026
Patent 12674084
RESIN COMPOSITION AND CURED PRODUCT THEREOF
3y 4m to grant Granted Jul 07, 2026
Patent 12673913
ALDEHYDE COMPOSITION
3y 2m to grant Granted Jul 07, 2026
Patent 12668579
(3aS,4aR,5S,7aS,9R,9aR)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a,9-methanoazuleno[5,6-d][1,3]dioxole
3y 3m to grant Granted Jun 30, 2026
Patent 12662564
CURABLE COMPOSITION, STORAGE CONTAINER, AND THREE-DIMENSIONAL OBJECT PRODUCING METHOD
3y 3m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
89%
Grant Probability
96%
With Interview (+7.2%)
1y 11m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1515 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month